Finance

5 Stocks To Watch This Week 8/10

(Photo Credit: Paul Lowry) In this week’s 5 Stocks to Watch, we take a look at the names with the largest shifts in EPS consensus ahead of earnings reports.  Monday, August 10 Tuesday, August 11 Friday, August 14 Take Two Interactive (TTWO) Information Technology, Software | Reports August 10, after the close On August 4, the…

Google Renames Itself “Alphabet”, Stock Soars

It’s long been difficult to catalogue everything that Google does, and apparently Google couldn’t keep up with anymore either because the company has unveiled a somewhat bizarre restructuring effort that will see “Google” become a wholly-owned subsidiary of a new holding company called “Alphabet.” Google directors will become Alphabet directors, Larry Page will be the holding…

10 Dividend Growth Stocks For Your Retirement Portfolios Aggregat

<<Read More: 20 Dividend Growth Stocks To Buy Today For Your Retirement Portfolios: Part 1  Introduction After an exhaustive search of the dividend growth stock universe I identified 20 dividend growth stocks that I felt were currently worthy of consideration for retirement portfolios based on valuation. In part 1 of this 2-part series found here I discussed the…

Thinking Outside The Commodity Box: Benchmark’s Investment

TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence. It’s often difficult to understand the global markets for critical minerals so The Gold Report narrowed it to three—lithium, cobalt and graphite—and brought in Simon Moores, managing director of London-based Benchmark Mineral Intelligence, and the…

Economic Cycles

Even with the rebound in second quarter growth, first half growth was still under 2%. Moreover, newly revised real GDP data reports even slower growth over the past few years. For some five years the consensus has forecast stronger growth right around the corner, despite the fact that it has consistently been too optimistic. This…

E

Shares of Inovio Pharmaceuticals (INO) are up for more then 22% today after the company announced a strategic partnership with AstraZeneca (AZN). More specifically Inovio is joining forces with MedImmune, which is the global biologics research and development arm for AstraZeneca. Under the terms of the deal AstraZeneca will obtain rights to INO-3112. Inovio’s INO-3112…